Talcum Powder Lawsuits | National Attorneys for Talcum Powder Ovarian Cancer Lawsuits
Talcum Powder Cancer Lawyers - We Only Get Paid if We Collect for You
J&J Establishes $8.9 Billion Trust to Settle All Present and Future Talcum Powder Cancer Lawsuits
The use of talcum powder for feminine hygiene has been found to cause ovarian cancer and other gynecological cancers, and tens of thousand of women around the nation have banded together to file talcum powder cancer claims against Johnson & Johnson. In April of 2023, following a decade of hard work, more than a dozen major court cases, and the tragic deaths of many plaintiffs from talcum powder cancer, Johnson & Johnson has finally come to the table to reach a settlement. A landmark trust of $8.9 billion has been established to provide compensation to approximately 70,000 victims of talcum powder ovarian cancer as well as any future cases that arise. Women who have suffered and died as a result of talcum powder ovarian cancer now have a clear pathway to seeking compensation for their suffering and losses.
Johnson & Johnson, a world leader in the area of personal care goods, fought the litigation for almost a decade before finally agreeing to issue compensation to women and families of women who have suffered from talcum powder ovarian cancer. Internal documents reveal the company was aware of the risk of ovarian and gynecologic cancers from talcum powder, and went to significant lengths to hide the threat from the public. The goodwill of J&J's reputation as a family-friendly company finally wore out when a critical mass of women called for justice. Today, as a result of these brave women, backed by the tireless efforts of our attorneys in pushing through thousands of talcum powder cancer lawsuits, Johnson's Baby Powder has been permanently pulled from markets worldwide. This victory is bittersweet--thousands of lives have been lost as a result of talcum powder cancer, and many more women will continue to suffer as their past exposure develops into cancer.
Valued at a staggering $428 billion, J&J declared bankruptcy in 2021 via a controversial method known as the Texas Two-Step designed to evade liability for talcum powder cancer. An appellate court threw out the bankruptcy in 2023. The new settlement includes a second bankruptcy filing and an agreement to pay out approximately $12.08 billion over time to settle talcum powder cancer claims.
It is not too late to file a claim for talcum powder cancer. Women and the family members of women who have suffered from ovarian cancer or another gynecologic cancer after using Johnson's Baby Powder may have grounds to file a claim for baby powder cancer. Filing a claim allows a woman and her family to seek compensation for the pain, suffering, medical expenses and loss associated with talcum powder cancer. This website provides access to comprehensive legal services from the nation's leading talcum powder ovarian cancer attorneys.
Women and the family members of women who have suffered from ovarian cancer or another gynecologic cancer and have a history of using talcum powder may be eligible to file a claim against Johnson & Johnson. Johnson & Johnson neglected to warn consumers of longstanding research linking baby powder use to cancer. Read full talcum powder cancer lawsuit information.
Leading the charge against Johnson & Johnson, these attorneys have a track record of winning large settlements in talcum powder cancer lawsuits. Read answers to the most common questions received about filing a baby powder cancer claim such as, How much does it cost to file a talcum powder lawsuit? For answers to your specific questions, please contact the firm for a free, no-obligation consultation. Read answers to talcum powder lawsuit FAQs.
From filing the second ever talcum powder cancer case nearly ten years ago, to getting talcum powder finally removed from the shelves for good, our attorneys are the national leaders on talcum powder cancer litigation. Filing with our talcum powder cancer attorneys ensures you will have the best representation available. We work on a contingency basis, meaning there are no fees unless we collect for you. Read full lawsuit information from national talcum powder cancer lawyers.
Even while creating an $8.9 billion settlement trust, J&J officials continue to shirk blame for talcum powder cancer. Yet internal company documents show corporate leaders have known for decades of the research linking talcum powder to cancer. Numerous studies dating back to the 1970s have concluded that talc particles found in the female reproductive system can result in gynecologic cancer. Read for full talcum powder cancer risk information.
Health organizations around the world have issued numerous talcum powder cancer warnings, but J&J never did. Meanwhile, American women continued to use the product, completely unaware of the danger. Finally, in August of 2022, J&J announced talcum powder would be pulled from shelves permanently throughout the world. Read full talcum powder cancer warning information.
Talcum Powder Cancer Timeline
Baby Powder Cancer Research Emerges
1971: A study published by Dr. Henderson showed the first evidence of a link between talcum powder an cancer.
1982: Dr. Cramer's epidemiologic study is the first to look at the risk in a pointed fashion. Cramer concluded talc use could increase a woman's chance of developing ovarian cancer by 92%. The release of this study earned Dr. Cramer a visit from Dr. Bruce Semple, an employee of Johnson & Johnson. Dr. Semple urged Cramer to down play the risk of ovarian cancer from talcum powder dusting of the perineum. Dr. Cramer countered by urging Johnson & Johnson to warn consumers of the risk.
Since 1982, more than 20 epidemiological studies have produced evidence documenting an increased risk for ovarian cancer from talcum powder use. Evidence presented to the jury indicates J&J and other industry officials were aware of the studies as they were published.
J&J Develops a Strategy to Conceal the Risk of Baby Powder Cancer
1986: A Johnson & Johnson "Technological Forecast" - an internal company document - describes talc as without health benefits. The company acknowledged, internally, that the safety of talcum powder was in question and that the health benefits of talcum powder were unknown.
1992: In response to declining sales of talc-based body products such as Johnson's Baby Powder and Shower to Shower, J&J officials launch a marketing campaign directed at African American and Hispanic women in order to increase sales among those populations.
Shortly thereafter, J&J joins the newly formed "Talc Interested Party Task Force". Comprised of representatives from the cosmetic and manufacturing industries, the task force sets out to create a "defense strategy" to keep talc unregulated.
1994: Dr. Samuel Epstein of the Cancer Prevention Coalition appeals to J&J to withdraw talcum powder products or, at a minimum, warn consumers of the link between perineal dusting with talcum powder and ovarian cancer development.
Numerous Companies Stop Using Talc for Internal Use
1995: Condom industry voluntary stops using talcum powder to dust its products, due to increasing evidence indicating talcum powder causes ovarian cancer.
1997: Internal company memos show employees within Johnson & Johnson are not in agreement about the appropriate course of action for responding to the talcum powder cancer risk. Dr. Wehner, the company's head toxicologist, wrote to Michael Chudkowski, the manager of preclinical toxicology, addressing concerns that the company was publicly lying about the safety of talcum powder for perneal dusting. This exchange is pivotal, because Wehner compares J&J's actions to the tobacco industry's denial of the obvious risk of lung cancer from smoking.
1998: Many internal documents have revealed the companies involved were internally strategizing for a fight against the talcum powder cancer risk while publicly acting as if nothing was happening. There is a characteristic document from 1998 where Luzenac (talc manufacturer) requested that scientists "from the club" - those on the talc industry's side - be brought in to oppose the classification of talc as carcinogenic.
1998: Quietly, without fanfare, a subsidiary of Johnson & Johnson - Janssen Pharmaceuticals - changed the contents of its diaphragm labels, omitting an instruction to use talcum powder on the product. Similar to the cessation of talc being used in the condom industry, this quiet action speaks volumes, indicating the company was cognizant of the risk posed to women by talcum powder.
J&J's Talc Supplier Concedes to the Baby Powder Cancer Risk
2002: Luzenac formally initiates a strategy for responding to product liability litigation for talcum powder. Simultaneously, the companies continue to fight to classification of talc as a carcinogen by various health organizations.
2005: The World Health Organization's International Agency for Research on Cancer (IARC) votes to classify talc as a 2B carcinogen, stating the product is a possible carcinogen based on consistent research on the talcum powder cancer risk.
2006: Luzenac, the talc mining company that supplies raw talc to J&J factories, begins stamping its product with a talc cancer warning. Johnson & Johnson has still never warned consumers of the potential risk.
Talcum Powder Cancer Cases Are Filed
2013: The first talcum powder cancer case was filed, followed by as many as 70,000 more over the ensuing decade.
2022: After decades of fighting to rid the world of this silent threat, our attorneys celebrated J&J's announcement that it was pulling talcum powder products from markets worldwide on a permanent basis.
2023: Under the leadership of our talcum powder cancer attorneys, J&J announced the creation of a $8.9 billion settlement trust to compensate victims of talcum powder cancer, now and in the future. Mourning the loss of thousands of women from gynecologic cancer, we celebrate their courage in speaking out against one of the world's largest personal care corporations.
Disclaimer: The choice of an attorney is an important decision and should not be based solely upon advertisements. Past results afford no guarantee of future results. Every case is different and must be judged on its own merits. The accident, injury, personal injury, and/or other legal information offered herein by OnderLaw, LLC, is not formal legal advice, nor is it the formation of an attorney client relationship. In order for our firm to be considered your attorney there must be a signed agreement between the client and the firm.
OnderLaw, LLC is a National Law Firm based in St. Louis, Missouri representing clients throughout the United States in national federal MDL products liability litigation.